Technical Analysis for QGEN - Qiagen N.V.

Grade Last Price % Change Price Change
D 46.78 0.60% 0.28
QGEN closed up 0.6 percent on Friday, May 14, 2021, on 63 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down
Historical QGEN trend table...

Date Alert Name Type % Chg
NR7 Range Contraction 0.00%
Oversold Stochastic Weakness 0.00%
Oversold Stochastic Weakness 0.60%
Slingshot Bearish Bearish Swing Setup 1.08%
Down 3 Days in a Row Weakness 1.08%
Down 4 Days in a Row Weakness 1.08%
Down 5 Days in a Row Weakness 1.08%
Oversold Stochastic Weakness 1.08%
Down 3 Days in a Row Weakness 0.86%
Down 4 Days in a Row Weakness 0.86%
Older End-of-Day Signals for QGEN ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Qiagen N.V. Description

QIAGEN N.V., through its subsidiaries, provides sample and assay technologies worldwide. It offers approximately 500 core consumable products, such as sample and assay kits, and automated instrumentation systems that empower customers to transform raw biological samples into molecular information. The company's consumable products are used for plasmid deoxyribonucleic acid (DNA) purification, and ribonucleic acid purification and stabilization; genomic and viral nucleic acid purification; nucleic acid transfection; polymerase chain reaction (PCR) amplification; reverse transcription; DNA cleanup after PCR and sequencing; and DNA cloning and protein purification. The company sells the digene HC2 HPV Test, a signal-amplified test for high-risk strains of the human papillomavirus. It also offers co-development services for companion diagnostics, technology licensing and patent sales services, and custom services, including whole genome amplification, DNA sequencing, and non-cGMP DNA production on a contract basis. The company's instrumentation systems automate the use of sample and assay technologies into solutions for a range of laboratory needs enabling customers to perform nucleic acid sample preparation, assay setup, target detection, and other laboratory tasks. Its automated systems include QIAsymphony, a modular system; Rotor-Gene Q, a rotary real-time PCR cycler system; PyroMark, a high-resolution detection platform based upon the Pyrosequencing technology; QIAcube, a sample processing instrument; QIAxcel for nucleic acid separation in low- to high-throughput laboratories; and ESE-Quant Tube Scanners, an optical measurement device. The company serves customer classes, including molecular diagnostics laboratories; applied testing customers in fields, such as forensics, veterinary diagnostics, and food safety; pharmaceutical research and development groups, and academic researchers. QIAGEN N.V. was founded in 1986 and is headquartered in Venlo, the Netherlands.


Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Biotechnology Biology Acid Nature Molecular Biology Lab Testing Scanner Consumable Products Molecular Diagnostics Genome Food Safety Transcription Companion Diagnostic Forensics Laboratory Techniques Polymerase Chain Reaction Instrumentation Systems Papillomavirus Cloning DNA Sequencing HPV Pharmaceutical Research Qiagen Real Time Polymerase Chain Reaction Protein Purification Technology Licensing

Is QGEN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 59.0
52 Week Low 42.22
Average Volume 676,139
200-Day Moving Average 50.60
50-Day Moving Average 49.22
20-Day Moving Average 48.84
10-Day Moving Average 47.18
Average True Range 0.91
ADX 32.87
+DI 12.89
-DI 34.21
Chandelier Exit (Long, 3 ATRs ) 50.08
Chandelier Exit (Short, 3 ATRs ) 48.32
Upper Bollinger Band 52.95
Lower Bollinger Band 44.74
Percent B (%b) 0.25
BandWidth 16.81
MACD Line -1.07
MACD Signal Line -0.82
MACD Histogram -0.245
Fundamentals Value
Market Cap 10.7 Billion
Num Shares 229 Million
EPS 0.83
Price-to-Earnings (P/E) Ratio 56.43
Price-to-Sales 6.58
Price-to-Book 4.09
PEG Ratio 2.09
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 47.59
Resistance 3 (R3) 47.54 47.22 47.46
Resistance 2 (R2) 47.22 47.01 47.24 47.41
Resistance 1 (R1) 47.00 46.88 47.11 47.05 47.37
Pivot Point 46.67 46.67 46.73 46.70 46.67
Support 1 (S1) 46.46 46.47 46.57 46.51 46.19
Support 2 (S2) 46.13 46.34 46.16 46.15
Support 3 (S3) 45.91 46.13 46.10
Support 4 (S4) 45.97